Dihydroquercetin regulates HIF-1α/AKT/NR2B signalling to improve impaired brain function in rats with metabolic syndrome.

导出 LinkOut

翻译打印收藏纠错

作者： Yang,Fu ^[1] ; PeiPei,Yuan ^[2] ; Mengnan,Zeng ^[1] ; Qi,Zhang ^[2] ; Ying,Hou ^[1] ; Liyuan,Gao ^[2] ; Yaxin,Wei ^[1] ; Yajuan,Zheng ^[1] ; Weisheng,Feng ^[1] ; Xiaoke,Zheng ^[1]

作者单位： Department of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China. ^[1] The Engineering and Technology Center for Chinese Medicine Development of Henan Province, Zhengzhou 450046, China. ^[2]

关键词 Brain Dihydroquercetin HIF-1α/AKT/NR2B Hypertension Metabolic syndrome

DOI 10.1016/j.heliyon.2024.e29807

PMID 38737244

发布时间 2024-05-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Heliyon

2024年10卷9期

e29807页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Dihydroquercetin regulates HIF-1α/AKT/NR2B signalling to improve impaired brain function in rats with metabolic syndrome.

Heliyon

相似文献

Heliyon

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Dihydroquercetin regulates HIF-1α/AKT/NR2B signalling to improve impaired brain function in rats with metabolic syndrome.

Heliyon

相似文献

Heliyon

相关期刊

检索历史清除